Other Archives - Page 2 of 2 - Corcept Therapeutics

Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.

September 18, 2018

Lenze et al. • 2014 • Int J Geriatr Psychiatry. 2014;29(9):962-9.

Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486).

September 18, 2018

van der Lely et al. • 1991 • Ann Intern Med. 1991;114(2):143-4.

1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.

September 18, 2018

Hunt et al. • 2015 • Bioorg Med Chem Lett. 2015;25(24):5720-5.

Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.

September 18, 2018

Agrawal et al. • 2011 • Mol Pharmacol. 2011;80(3):389-99.

Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.

September 18, 2018

Andrade et al. • 2012 • J Neural Transm (Vienna). 2012;119(3):337-44.

The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness.

September 21, 2017

Moraitis et al. • 2017 • J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):114-120.

Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.

November 15, 2015

Vendruscolo et al. • 2015 • J Clin Invest. 2015;125(8):3193-7.

© 2024 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Your Privacy Choices